Cargando…
Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963242/ http://dx.doi.org/10.1186/1475-2875-9-S2-O4 |
| _version_ | 1782189251406856192 |
|---|---|
| author | Biagini, Giancarlo A Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Fisher, Nick Berry, Neil G O'Neill, Paul M Ward, Steve A |
| author_facet | Biagini, Giancarlo A Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Fisher, Nick Berry, Neil G O'Neill, Paul M Ward, Steve A |
| author_sort | Biagini, Giancarlo A |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2963242 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-29632422010-10-26 Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase Biagini, Giancarlo A Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Fisher, Nick Berry, Neil G O'Neill, Paul M Ward, Steve A Malar J Oral Presentation BioMed Central 2010-10-20 /pmc/articles/PMC2963242/ http://dx.doi.org/10.1186/1475-2875-9-S2-O4 Text en Copyright ©2010 Biagini et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Biagini, Giancarlo A Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Fisher, Nick Berry, Neil G O'Neill, Paul M Ward, Steve A Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase |
| title | Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase |
| title_full | Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase |
| title_fullStr | Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase |
| title_full_unstemmed | Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase |
| title_short | Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase |
| title_sort | development of a novel drug for uncomplicated malaria targeting the mitochondrial nadh:quinone oxidoreductase |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963242/ http://dx.doi.org/10.1186/1475-2875-9-S2-O4 |
| work_keys_str_mv | AT biaginigiancarloa developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT hillalasdair developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT mbekeanialison developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT shonealison developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT nixongemma developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT stockspaul developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT gibbonspeter developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT amewurichard developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT hongdavidw developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT bartonvictoria developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT pidathalachandra developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT chadwickjames developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT lepenseelouise developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT warmanashley developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT sharmaraman developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT fishernick developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT berryneilg developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT oneillpaulm developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase AT wardstevea developmentofanoveldrugforuncomplicatedmalariatargetingthemitochondrialnadhquinoneoxidoreductase |